Ligand validation:2ZUW

NDG: 2-acetamido-2-deoxy-alpha-D-glucopyranose

NDG is a Ligand Of Interest in 2ZUW designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2ZUW_NDG_A_4001	98%	56%	0.048	0.973	0.59	1.08	-	1	0	0	100%	1
2ZUW_NDG_D_4004	96%	50%	0.053	0.962	0.63	1.28	-	3	0	0	100%	1
2ZUW_NDG_C_4003	94%	57%	0.061	0.959	0.62	1.04	-	1	0	0	100%	1
2ZUW_NDG_B_4002	93%	50%	0.059	0.954	0.63	1.27	-	3	0	0	100%	1
2ZUV_NDG_B_2002	100%	55%	0.036	0.982	0.59	1.14	-	2	0	0	100%	1
3WFZ_NDG_D_801	84%	55%	0.1	0.962	0.51	1.2	-	1	0	0	100%	1
2ZUU_NDG_D_4004	84%	57%	0.118	0.98	0.51	1.14	-	1	0	0	100%	1
4OCJ_NDG_A_401	99%	66%	0.042	0.978	0.55	0.75	-	-	0	0	100%	1
3MAW_NDG_A_519	98%	71%	0.042	0.973	0.52	0.61	-	-	0	0	93%	1
4GVF_NDG_A_401	97%	29%	0.06	0.978	1.66	1.18	4	2	0	0	100%	0.7
2UVO_NDG_B_1176	97%	71%	0.059	0.975	0.42	0.68	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.